Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease (Front. Oncol, (2020), 10, (580141), 10.3389/fonc.2020.580141)

Larissa Di Villeneuve, Ive Lima Souza, Fernanda Davila Sampaio Tolentino, Renata Ferrarotto, Gustavo Schvartsman

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article, there was a mistake in Figure 1 and Figure 2 as published. The proposed algorithms were in disagreement among all authors and thus corrected. The corrected Figures appears below.

Original languageEnglish (US)
Article number669486
JournalFrontiers in Oncology
Volume11
DOIs
StatePublished - Apr 9 2021

Keywords

  • androgen receptor
  • drug resistance
  • ERBB-2 receptor
  • gene fusion
  • immunotherapy
  • molecular targeted therapy
  • salivary gland cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease (Front. Oncol, (2020), 10, (580141), 10.3389/fonc.2020.580141)'. Together they form a unique fingerprint.

Cite this